Engineering and Development

Management and Executive

Legal and Compliance

Sales

Chief Operating Officer

Subcutaneous RYBREVANT®▼(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer

Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer

Halozyme CEO targets M&A and new deals as IRA uncertainty on pharma subsides

Halozyme names Cortney Caudill as COO

Specialty Account Manager

Halozyme, Inc. is dedicated to making a significant impact in the healthcare industry. As a Specialty Account Manager, you will drive new prescriptions for Halozyme products by educating and influencing targeted specialties, while maintaining a high level of knowledge about managed care insurance plans and payer programs.

Specialty Account Manager-Louisville, KY

Director Talent Acquisition

Senior Specialty Account Manager

Sign up with Google

Sign in with Google